Bandingkan Harga & Kinerja Darmi Bersaudara Tbk. (KAYU) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Darmi Bersaudara Tbk. dan Organon Pharma Indonesia Tbk.: Darmi Bersaudara Tbk. diperdagangkan di Rp18 (kapitalisasi pasar 11,97 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 8,7× kapitalisasi pasar Darmi Bersaudara Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KAYU | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 11,97 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Darmi Bersaudara Tbk.
PT Darmi Bersaudara Tbk (the Entity) was established based on the Notarial Deed of Ellen, S.H., Notary in Surabaya, No. 3, dated June 3, 2010, which was approved by the Ministry of Law and Human Rights of the Republic of Indonesia based on letter No. AHU-37538.AH.01.01.Tahun 2010, dated July 29, 2010.
Selengkapnya di halaman KAYU →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
